Biểu Hiện Transgenic IL15 Tăng Cường Hoạt Tính Chống U Glioma Của Tế Bào T CAR IL13Rα2 Nhưng Dẫn Đến Xuất Hiện Các Biến Thể Mất Kháng Nguyên
Tóm tắt
Từ khóa
Tài liệu tham khảo
Omuro, 2013, Glioblastoma and other malignant gliomas: a clinical review, JAMA, 310, 1842, 10.1001/jama.2013.280319
Thakkar, 2014, Epidemiologic and molecular prognostic review of glioblastoma, Cancer Epidemiol Biomarkers Prev, 23, 1985, 10.1158/1055-9965.EPI-14-0275
Arvold, 2014, Treatment options and outcomes for glioblastoma in the elderly patient, Clin Interv Aging, 9, 357
Konar, 2017, A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord, J Neurosurg Pediatr, 19, 239, 10.3171/2016.8.PEDS1631
Suryadevara, 2015, Immunotherapy for malignant glioma, Surg Neurol Int, 6, S68, 10.4103/2152-7806.151341
Krebs, 2013, Genetically modified T cells to target glioblastoma, Front Oncol, 3, 322, 10.3389/fonc.2013.00322
Kahlon, 2004, Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells, Cancer Res, 64, 9160, 10.1158/0008-5472.CAN-04-0454
Krenciute, 2016, Characterization and functional analysis of scFv-based chimeric antigen receptors to redirect T cells to IL13Ralpha2-positive Glioma, Mol Ther, 24, 354, 10.1038/mt.2015.199
Ahmed, 2010, HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors, Clin Cancer Res, 16, 474, 10.1158/1078-0432.CCR-09-1322
Johnson, 2015, Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma, Sci Transl Med, 7, 275ra22, 10.1126/scitranslmed.aaa4963
Chow, 2013, T cells redirected to EphA2 for the immunotherapy of glioblastoma, Mol Ther, 21, 629, 10.1038/mt.2012.210
O'Rourke, 2015, Pilot study of T cell redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma, Neuro Oncol, 17, v110, 10.1093/neuonc/nov218.15
Brown, 2016, Regression of glioblastoma after chimeric antigen receptor T-cell therapy, N Engl J Med, 375, 2561, 10.1056/NEJMoa1610497
Brown, 2015, Bioactivity and Safety of IL13Ralpha2-redirected chimeric antigen receptor CD8+ T cells in patients with recurrent glioblastoma, Clin Cancer Res, 21, 4062, 10.1158/1078-0432.CCR-15-0428
Ahmed, 2017 20, HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial, JAMA Oncol, 10.1001/jamaoncol.2017.0184
Ahmed, 2015, Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor-modified T cells for the immunotherapy of HER2-positive sarcoma, J Clin Oncol, 33, 1688, 10.1200/JCO.2014.58.0225
Pule, 2008, Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma, Nat Med, 14, 1264, 10.1038/nm.1882
Park, 2016, CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date, Blood, 127, 3312, 10.1182/blood-2016-02-629063
Ruella, 2016, Chimeric antigen receptor T cells for B cell neoplasms: choose the right CAR for you, Curr Hematol Malig Rep, 11, 368, 10.1007/s11899-016-0336-z
Turtle, 2016, CD19-Targeted chimeric antigen receptor-modified T-cell immunotherapy for B-cell malignancies, Clin Pharmacol Ther, 100, 252, 10.1002/cpt.392
Dotti, 2014, Design and development of therapies using chimeric antigen receptor-expressing T cells, Immunol Rev, 257, 107, 10.1111/imr.12131
Newick, 2016, CAR T Cell Therapy for Solid Tumors, Ann Rev Med, 68, 139, 10.1146/annurev-med-062315-120245
Zhang, 2015, Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma, Clin Cancer Res, 21, 2278, 10.1158/1078-0432.CCR-14-2085
Liu, 2012, IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity, J Clin Invest, 122, 2221, 10.1172/JCI59535
Wilkie, 2010, Selective expansion of chimeric antigen receptor-targeted T-cells with potent effector function using interleukin-4, J Biol Chem, 285, 25538, 10.1074/jbc.M110.127951
Foster, 2008, Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor, J Immunother, 31, 500, 10.1097/CJI.0b013e318177092b
Hoyos, 2010, Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety, Leukemia, 24, 1160, 10.1038/leu.2010.75
Quintarelli, 2007, Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes, Blood, 110, 2793, 10.1182/blood-2007-02-072843
Fedorov, 2013, PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses, Sci Transl Med, 5, 215ra172, 10.1126/scitranslmed.3006597
Leen, 2014, Reversal of tumor immune inhibition using a chimeric cytokine receptor, Mol Ther, 22, 1211, 10.1038/mt.2014.47
Sarkaria, 2007, Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel, Mol Cancer Ther, 6, 1167, 10.1158/1535-7163.MCT-06-0691
Xu, 2014, Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15, Blood, 123, 3750, 10.1182/blood-2014-01-552174
Speck, 1987, Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer, Mol Cell Biol, 7, 1101
Smith-Garvin, 2009, T cell activation, Annu Rev Immunol, 27, 591, 10.1146/annurev.immunol.021908.132706
Cieri, 2013, IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors, Blood, 121, 573, 10.1182/blood-2012-05-431718
Hurton, 2016, Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells, Proc Natl Acad Sci USA, 113, E7788, 10.1073/pnas.1610544113
Wherry, 2015, Molecular and cellular insights into T cell exhaustion, Nat Rev Immunol, 15, 486, 10.1038/nri3862
Vera, 2006, T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells, Blood, 108, 3890, 10.1182/blood-2006-04-017061
Santos, 2009, Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase, Nat Med, 15, 338, 10.1038/nm.1930
Koneru, 2015, IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo, Oncoimmunology, 4, e994446, 10.4161/2162402X.2014.994446
Chinnasamy, 2012, Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice, Clin Cancer Res, 18, 1672, 10.1158/1078-0432.CCR-11-3050
Hegde, 2013, Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma, Mol Ther, 21, 2087, 10.1038/mt.2013.185
Grada, 2013, TanCAR: A novel bispecific chimeric antigen receptor for cancer immunotherapy, Mol Ther Nucleic Acids, 2, e105, 10.1038/mtna.2013.32
Wilkie, 2012, Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling, J Clin Immunol, 32, 1059, 10.1007/s10875-012-9689-9
Long, 2015, 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors, Nat Med, 21, 581, 10.1038/nm.3838
Guest, 2005, The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens, J Immunother, 28, 203, 10.1097/01.cji.0000161397.96582.59
Hudecek, 2015, The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity, Cancer Immunol Res, 3, 125, 10.1158/2326-6066.CIR-14-0127
Sampson, 2014, EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss, Clin Cancer Res, 20, 972, 10.1158/1078-0432.CCR-13-0709
Kochenderfer, 2010, Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells, Blood, 116, 3875, 10.1182/blood-2010-01-265041